CTRI/2024/01/061120
Not Yet Recruiting
N/A
Validation and Standardisation of tool to identify the risks of cognitive decline (Medhahrasa) in apparently healthy middle age group
Dr Nithya P R0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: F028- Dementia in other diseases classified elsewhere
- Sponsor
- Dr Nithya P R
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects between the age group of 30\-70 years.
- •Subjects willing to sign the informed consent form.
- •Apparently physically and mentally healthy subjects.
Exclusion Criteria
- •Known case of any major psychiatric illnesses.
- •Subjects with known history of uncontrolled diabetes mellitus, hypertension or other metabolic conditions.
- •Subjects under the influence of psychoactive substance
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Validation and Standardization of a tool to assess mental strengthCTRI/2023/08/056962Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan
Recruiting
N/A
Development and validation of an instrument for the determination of resistance and promotion of coping strategies in people with diabetes mellitusPeople with type 1 or type 2 diabetes mellitusE10E11Type 1 diabetes mellitusType 2 diabetes mellitusDRKS00009413Frankfurt University of Applied Siences60
Not Yet Recruiting
N/A
Tool development to assess the knowledge and awareness of adult men towards screening of prostate cancer and testicular cancerCTRI/2021/08/035712A
Recruiting
N/A
Development and trial of a tool to determine qualification-oriented staffing ratios using a new scientifically based procedure for standardizing staffing requirements. Pilot programme in accordance with Paragraph 8, Section 3b of the German Social Code, Vol. 11 on behalf of the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband)not applicableDRKS00031773Spitzenverband Bund der Krankenkassen1,800
Completed
Phase 3
TOOL DEVELOPMENT FOR MEASURING AVARANA (OCCLUSION OF BODY CHANNELS) AND ASSESSMENT OF THE EFFECT OF SELECTED AYURVEDIC ANTIAVARANA DRUGS, IN METABOLIC SYNDROMEHealth Condition 1: null- Participants with and without Metabolic syndromeCTRI/2018/05/013837DrPriyaS220